Allergan's Potential Baldness Cure Clears One Hurdle, Heads for the Hard Part
Posted on August 19, 2011 at 12:48 PM EDT
Latisse for baldness is now "optimally resourced" in Allergan's R&D budget and if any positive data emerge Allergan will go immediately to mass testing to prove it's effective.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here